Abstract

Case Report

Short and Medium-Term Evaluation of Patients in Coronary Post-Angioplasty: Préliminary results at the Cardiology Department of the Hospital University Aristide Le Dantec of Dakar (Senegal): Study on 38 Cases

Dioum M*, Aw F, Masmoudi K, Gaye ND, Sarr SA, Ndao SCT, Mingou J, Ngaidé AA, Diack B, Bodian M, Ndiaye MB, Diao M and Ba SA

Published: 20 February, 2017 | Volume 2 - Issue 1 | Pages: 008-012

Introduction: Coronary angioplasty is a safe therapeutic method for coronary disease. However, its major obstacles remain the occurrence of stent thrombosis (ST) and in-stent restenosis (ISR). The aim of this study was to evaluate the short-term and medium-term results of coronary angioplasty patients in the cardiology department of Aristide Le Dantec hospital in Dakar.

Methodology: It was a longitudinal, descriptive and analytical study over a period of 12 months (April 2014 to April 2015) with a follow-up at 6 months. Was included any patient who had a coronary angioplasty with stent placement.

Results: Thirty-eight patients had been included with a male predominance and a sex ratio of 5.32. The average age was 57.94 years. Cardiovascular risk factors were mainly smoking (57.9%) and coronary heredity (42.1%), followed by hypertension (39.5%) and diabete (34.2%). The indications for angioplasty were acute coronary syndromes TS(+) and TS(-) respectively (50%) and (23.7%) and stable angina (26.3%). The right femoral approach was almost exclusive (97.4%). Coronary angiography revealed a predominance of anterior interventricular affection (84.2%). Type B lesions were the most frequent (68.4%). The single-truncal valve affection was predominant (76.3%). Direct stenting accounted for 63.2% of procedures. Twenty-one bare stents (55.3%) and 17 active stents (44.7%) were implanted. The results were excellent (94.7%). One case of acute stent thrombosis was noted. Echocardiography of dobutamine stress during follow-up was positive in 04 patients (12.5%). The control coronary angiography performed in two patients revealed an ISR. The predictive factors for restenosis were dominated by a deterioration in the segmental kinetics (p=0.009), in the diastolic function (p=0.002), the systolic function (p=0.003), a high post angioplasty troponin (p=0.004), the presence of calcifications (p=0.004) and a high SYNTAX score (p=0.021).

Conclusion: According to these results, Angioplasty is an effective therapy for coronary disease. However, a correct intake of double platelet antiaggregants and clinical and non-invasive screening are required for follow-up to avoid stent thrombosis or restenosis.

Read Full Article HTML DOI: 10.29328/journal.jccm.1001006 Cite this Article Read Full Article PDF

References

  1. The top 10 causes of death. 2013; Cité 30. Disponible sur: Ref.: https://goo.gl/bLfjF2
  2. Maboury Diao, Serigne Abdou B. Maladies cardio-vasculaires et complications. CHU le Dantecm, Dakar-Sénégal 2013. Ref.: https://goo.gl/KgXNvJ
  3. Philippe F, Dibie A, Larrazet F, Meziane T, Folliguet T et al. Les stents à élution de médicaments: preuves, incertitudes et pratiques. Ann Cardiol Angéiol. 2005; 54: 201-211. Ref.: https://goo.gl/ascnp5
  4. Chevalier B, Blanchard D, Berland J, Carrié D, Gilard M et al. Endoprothèses actives: Indications, limites et développements. Arch Mal Coeur Vaiss. 2005; 98: 1013-1021. Ref.: https://goo.gl/CuHW2l
  5. Bauters C, Hubert E, Prat A, Bougrimi K, Van Belle EA, et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol. 1998; 31: 1291-1298. Ref.: https://goo.gl/smViit
  6. Serruys PW, Kay IP, Disco C, Deshpande NV, de Feyter PJ. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and MUSIC trials. Multicenter Ultrasound Stent In Coronaries. J Am Coll Cardiol. 1999; 34: 1067-1074. Ref.: https://goo.gl/8YghtL
  7. Schiele F. Predictive factors of restenosis: what changes with "active" stents? Pathology Biology. 2004; 52: 206-211. Ref.: https://goo.gl/RAkuK4
  8. Zouaoui W, Ouldzein H, Boudou N, Dumonteil N, Bongard V, et al. Factors predictive for in-hospital mortality following percutaneous coronary intervention. Arch Cardiovasc Dis. 2008; 101: 443-448. Ref.: https://goo.gl/MxVZQH
  9. Wilensky RL, Selzer F, Johnston J, Laskey WK, Klugherz BD, et al. Relation of percutaneous coronary intervention of complex lesions to clinical outcomes (from the NHLBI Dynamic Registry). Am J Cardiol. 2002; 90: 216-221. Ref.: https://goo.gl/XDUHkh
  10. Assali AR, Moustapha A, Sdringola S, Salloum J, Awadalla H et al. The dilemma of success: percutaneous coronary interventions in patients > or = 75 years of age-successful but associated with higher vascular complications and cardiac mortality. Catheter Cardiovasc Interv. 2003; 59: 195-199. Ref.: https://goo.gl/3wtkA1
  11. Cambou JP, Simon T, Mulak G, Bataille V, Danchin N. The French Registry of Acute ST Elevation or Non-ST-Elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics. Arch Mal Coeur Vaiss. 2007; 100: 524-534. Ref.: https://goo.gl/yHc6nN
  12. Ko DT, Atzema CL, Donovan LR, Graham MM, Huynh T. Rescue Percutaneous Coronary Interventions for Failed Fibrinolytic Therapy in ST-segment Elevation Myocardial Infarction. Am Heart J. 2011; 161: 764-770. Ref.: https://goo.gl/46D3YW
  13. Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on myocardial revascularization of the European Society of Cardiology (ESC), the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2010; 31: 2541-2619. Ref.: https://goo.gl/tfUL2t
  14. Chevalier B. American recommendations on coronary angioplasty. Consensus Cardio. 2012; 78: 1-4.
  15. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Eng J Med. 1994; 331: 489-495. Ref.: https://goo.gl/Mk8PT0
  16. Serruys PW, van Hout B, Bonnier H, Legrand V, Garcia E, et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (BENESTENT II). Lancet. 1998; 352: 673-681. Ref.: https://goo.gl/fWcRre
  17. Cutlip DE, Chauhan MS, Baim DS, Ho KK, Popma JJ, et al. Clinical Restenosis After Coronary Stenting: Perspectives From Multicenter Clinical Trials. J Am Coll Cardiol. 2002; 40: 2082-2089. Ref.: https://goo.gl/aOD490

Figures:

Figure 1

Figure 1

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More